EC Number | Protein Variants | Comment | Organism |
---|---|---|---|
3.5.4.B9 | F126A/W127A | site-directed mutagenesis, the N-terminal CD1 domain mutant, that shows disrupted dimerization at the predicted CD1-CD1 dimer interface, predominantly converts Apo3G to a monomer that binds single-stranded DNA, Alu RNA, and catalyzes processive C to U deaminations with 3'-5' deamination polarity, similar to wild-type Apo3G. The mutation causes severe disruption in oligomer formation resulting in about 92% monomers and 8% dimers, with no larger oligomer forms detected | Homo sapiens |
3.5.4.B9 | I314A/Y315A | site-directed mutagenesis, C-terminal CD2 domain mutant, C-terminal CD2 domain mutant, mutation at the Apo2 tetrameric interface and predicted CD1 oligomerization region, the mutant contains about 12% tetramers with no larger oligomeric forms | Homo sapiens |
3.5.4.B9 | additional information | comparison of Apo3G native and monomeric N-mutant F/W ssDNA substrate binding and catalysis, overview | Homo sapiens |
3.5.4.B9 | R313A/D316A/D317A/Q318A | site-directed mutagenesis, C-terminal CD2 domain mutant, mutation at the Apo2 tetrameric interface and predicted CD1 oligomerization region, the mutant contains about 12% tetramers with no larger oligomeric forms | Homo sapiens |
3.5.4.B9 | Y124A/Y125A | site-directed mutagenesis, the N-terminal CD1 domain mutant is composed of roughly 47% monomers, 42% dimers, 10% tetramers, and 1% much larger molecular mass species of about 650 kDa | Homo sapiens |
EC Number | KM Value [mM] | KM Value Maximum [mM] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|---|
3.5.4.B9 | additional information | - |
additional information | pre-steady state and steady state kinetics, stopped-flow fluorescence measurements, detailed overview | Homo sapiens |
EC Number | Localization | Comment | Organism | GeneOntology No. | Textmining |
---|
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
3.5.4.B9 | 2'-deoxycytidine + H2O | Homo sapiens | in ssDNA | 2'-deoxyuridine + NH3 | - |
? |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
3.5.4.B9 | Homo sapiens | - |
- |
- |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
3.5.4.B9 | 2'-deoxycytidine + H2O | in ssDNA | Homo sapiens | 2'-deoxyuridine + NH3 | - |
? |
EC Number | Subunits | Comment | Organism |
---|---|---|---|
3.5.4.B9 | More | Apo3G has a catalytically inactive N-terminal CD1 domain and an active C-terminal CD2 domain. Apo3G exists as monomers, dimers, tetramers, and higher order oligomers whose distributions depend on DNA substrate and salt | Homo sapiens |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
3.5.4.B9 | Apo3G | - |
Homo sapiens |
3.5.4.B9 | APOBEC3G | - |
Homo sapiens |
3.5.4.B9 | single-stranded DNA deoxycytidine deaminase | - |
Homo sapiens |
3.5.4.B9 | single-stranded DNA-dependent deoxycytidine deaminase | - |
Homo sapiens |
3.5.4.B9 | ssDNA deoxycytidine deaminase | - |
Homo sapiens |
EC Number | Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
---|---|---|---|---|
3.5.4.B9 | 37 | - |
assay at | Homo sapiens |
EC Number | pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|---|
3.5.4.B9 | 7.3 | - |
assay at | Homo sapiens |